Inhibition of diabetes in non-obese diabetic mice by nicotinamide treatment for 5 weeks at the early age

烟酰胺治疗5周,早期抑制非肥胖糖尿病小鼠的糖尿病

阅读:1

Abstract

To know the effects of nicotinamide (NCT) treatment for 5 weeks at the early age on insulitis and development of diabetes in non-obese diabetic (NOD) mice, this experiment was performed. Ten ICR (Institute of Cancer Research) and 15 female NOD mice at 4 weeks of age were used. Mice were assigned to ICR and NOD groups, and NOD mice were randomly divided to control and NCT-treated groups. NCT was administered to mice orally as a solution and in a dose of 500 mg/kg body weight a day from the age of 4 to 8 weeks. Diabetes onset was 18 weeks of age in control group, and 22 weeks of age in NCT-treated group. Cumulative incidences of diabetes at 25 weeks of age in control and NCT-treated NOD mice were 63 and 29%, respectively. Insulitis occurred in all NOD mice. Incidence of insulitis in total islets was decreased by NCT treatment in diabetic NOD mice, but intensity of insulitis was not improved by NCT treatment. Blood glucose level was increased markedly, and plasma insulin level was decreased by diabetes development in NOD mice. Plasma triglycerides and total cholesterol levels were increased in diabetic mice than in non-diabetic mice. In conclusion, these results suggest that NCT treatment for 5 weeks at the early age in NOD mice inhibits development of diabetes and insulitis in diabetic NOD mice.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。